Raymond Scott Turner

发表

Early Detection of Alzheimer’s Disease Using Patient Neuropsychological and Cognitive Data and Machine Learning Techniques

Lin-Ching Chang, Xiong Jiang, Ibrahim Almubark, 2019, 2019 IEEE International Conference on Big Data (Big Data).

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2020, Scientific Reports.

Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease

Andrew J. Saykin, Arthur W. Toga, Qianjin Feng, 2017, Scientific Reports.

Multimodal Hippocampal Subfield Grading For Alzheimer’s Disease Classification

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2019, Scientific Reports.

GenEpi: gene-based epistasis discovery using machine learning

Michael W. Weiner, Yen-Jen Oyang, Arthur W. Toga, 2018, BMC Bioinformatics.

A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2019, Scientific Reports.

A comparison of classification methods for differentiating fronto‐temporal dementia from Alzheimer's disease using FDG‐PET imaging

Raymond Scott Turner, C. DeCarli, W. Jagust, 2004, Statistics in medicine.

A 5-min Cognitive Task With Deep Learning Accurately Detects Early Alzheimer's Disease

Raymond Scott Turner, Xiong Jiang, Lin-Ching Chang, 2020, Frontiers in Aging Neuroscience.

11C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease

Jeih-San Liow, Cheryl L. Morse, Robert B. Innis, 2016, Neurobiology of Aging.

Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer's disease

Jeih-San Liow, Cheryl L. Morse, Robert B. Innis, 2017, Neurobiology of Aging.

Alzheimer disease pathology in cognitively healthy elderly: A genome-wide study

Jurg Ott, David A. Bennett, Ronald C. Petersen, 2011, Neurobiology of Aging.

Potential New Approaches for Diagnosis of Alzheimer's Disease and Related Dementias

Raymond Scott Turner, B. Albensi, T. Stubbs, 2020, Frontiers in Neurology.

Animal Model Stable -Secretase Activity and Presynaptic Cholinergic Markers During Progressive Central Nervous System Amyloidogenesis in Tg2576 Mice

Raymond Scott Turner, K. Frey, C. D'amato, 2002 .

Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer’s disease

Raymond Scott Turner, Xiong Jiang, G. Rebeck, 2020, bioRxiv.

A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Communications Medicine.

Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, GeroScience.

CCR5 deficiency normalizes TIMP levels, working memory, and gamma oscillation power in APOE4 targeted replacement mice

Raymond Scott Turner, K. Conant, G. Rebeck, 2022, Neurobiology of Disease.

Idiopathic Rapid Eye Movement Sleep Behavior Disorder Is a Harbinger of Dementia with Lewy Bodies

Raymond Scott Turner, 2002, Journal of geriatric psychiatry and neurology.

An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Aging.

Raymond Scott Turner, Charles Withington, 2022, Frontiers in Neurology.

Coexisting adult polyglucosan body disease with frontotemporal lobar degeneration with transactivation response DNA-binding protein-43 (TDP-43)-positive neuronal inclusions

Raymond Scott Turner, B. Crain, B. Harris, 2013, Neurocase.

Temporoparietal hypometabolism is common in FTLD and is associated with imaging diagnostic errors

Raymond Scott Turner, C. DeCarli, W. Jagust, 2011 .

11C-PBR28 PET detects translocator protein in a patient with astrocytoma and Alzheimer disease

Raymond Scott Turner, Emily M. Page, R. Innis, 2017, Neurology.

Increasing access to cognitive screening in the elderly: Applying natural language processing methods to speech collected over the telephone

Raymond Scott Turner, B. Elvevåg, Brigid Reynolds, 2022, Cortex.

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Communications.

Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease

Raymond Scott Turner, M. Jung, Hyejin Yoon, 2013, Experimental Neurology.

Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization

Keith A. Johnson, Raymond Scott Turner, Joanne L. Lord, 2021, Scientific Reports.

Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology

Sterling C. Johnson, David T. Jones, Taylor W. Schmitz, 2016, Nature Communications.

The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores

Mark T. W. Ebbert, Raymond Scott Turner, Owen Carmichael, 2021, Communications Biology.

Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Spontaneous intracranial hypotension causing reversible frontotemporal dementia.

Raymond Scott Turner, N. Foster, K. Adams, 2002, Neurology.

Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease

Sterling C. Johnson, Christine L. Tardif, John X. Morris, 2021, Nature Communications.

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

James B. Brewer, Raymond Scott Turner, Paul S. Aisen, 2015, Neurology.

Non-coding variability at the APOE locus contributes to the Alzheimer’s risk

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2019, Nature Communications.

Four distinct trajectories of tau deposition identified in Alzheimer’s disease

Sterling C. Johnson, John X. Morris, Keith A. Johnson, 2021, Nature Medicine.

Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease

Eric M Reiman, Robert A Koeppe, Kewei Chen, 2019, JAMA neurology.

Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Communications.

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Alzheimer's disease in man and transgenic mice: females at higher risk.

Raymond Scott Turner, 2001, The American journal of pathology.

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2021, Translational Psychiatry.

KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2021, Nature Communications.

A tetra(ethylene glycol) derivative of benzothiazole aniline ameliorates dendritic spine density and cognitive function in a mouse model of Alzheimer's disease

Raymond Scott Turner, Hey-Kyoung Lee, D. Pak, 2014, Experimental Neurology.

The trend of disruption in the functional brain network topology of Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2021, Scientific Reports.

Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2022, GeroScience.

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2017, Nature Communications.

Probable diffuse Lewy body disease presenting as REM sleep behavior disorder

Raymond Scott Turner, R. Chervin, D. Kuhl, 1997, Neurology.

Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2023, Communications Medicine.

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2019, Scientific Reports.

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status

Sterling C. Johnson, Nick C Fox, Keith A. Johnson, 2021, Translational Psychiatry.

Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.

Raymond Scott Turner, C. DeCarli, W. Jagust, 2011, Archives of neurology.

Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients

Keith A. Johnson, Raymond Scott Turner, Charles D. Smith, 2022, Nature Aging.

Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states

Islem Rekik, Mohamed Ali Mahjoub, Keith A. Johnson, 2018, Scientific Reports.

Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease

Raymond Scott Turner, Xiong Jiang, G. Esposito, 2020, Annals of neurology.

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2019, Nature Communications.

The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial

Raymond Scott Turner, Susie A. Sami, David M. Shade, 2018, Trials.

Low CD4 nadir exacerbates the impacts of APOE ε4 on functional connectivity and memory in adults with HIV.

Raymond Scott Turner, Xiong Jiang, R. Ellis, 2021, AIDS.

Biomarkers of alzheimer’s disease and mild cognitive impairment: are we there yet?

Raymond Scott Turner, R. Scott Turner, 2003, Experimental Neurology.

Matrix disequilibrium in Alzheimer’s disease and conditions that increase Alzheimer’s disease risk

Raymond Scott Turner, K. Conant, Matthew Amontree, 2023, Frontiers in Neuroscience.

The pathology of REM sleep behavior disorder with comorbid Lewy body dementia.

Raymond Scott Turner, R. Chervin, C. D'amato, 2000, Neurology.

Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2021, Nature Communications.

Class-based antiretroviral exposure and cognition among women living with HIV (WLWH).

Raymond Scott Turner, A. Adimora, L. Rubin, 2022, AIDS research and human retroviruses.

Inhibition of discoidin domain receptor (DDR)-1 with nilotinib alters CSF miRNAs and is associated with reduced inflammation and vascular fibrosis in Alzheimer’s disease

Raymond Scott Turner, R. Varghese, C. Moussa, 2023, Journal of Neuroinflammation.

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease

Raymond Scott Turner, P. Aisen, R. Turner, 2017, Journal of Neuroinflammation.

Spontaneous intracranial hypotension causing reversible frontotemporal dementia.

Raymond Scott Turner, W. Dillon, K. Adams, 2002, Neurology.

Non-coding variability at the APOE locus contributes to the Alzheimerâ€TMs risk

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2019 .

Nilotinib and bosutinib modulate pre-plaque alterations of blood immune markers and neuro-inflammation in Alzheimer’s disease models

Raymond Scott Turner, R. Turner, C. Moussa, 2015, Neuroscience.

Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2019, Scientific Reports.

FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease

Sterling C. Johnson, David T. Jones, Keith A. Johnson, 2020, Nature Communications.

A blood-based signature of cerebrospinal fluid Aβ1–42 status

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2019, Scientific Reports.

Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2018, Scientific Reports.

Alzheimer disease pathology in cognitively healthy elderly: A genome-wide study

Raymond Scott Turner, J. Ott, D. Bennett, 2011, Neurobiology of Aging.

Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Aging.

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts

Sterling C. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.

Raymond Scott Turner, C. DeCarli, W. Jagust, 2011, Archives of neurology.

Prognostic relevance of gait-related cognitive functions for dementia conversion in amnestic mild cognitive impairment

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2023, BMC Geriatrics.

Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease

Raymond Scott Turner, M. Jung, Hyejin Yoon, 2013, Experimental Neurology.

A blood-based signature of cerebrospinal fluid Aβ1–42 status

Raymond Scott Turner, Sherye A. Sirrel, Alice D. Brown, 2019, Scientific Reports.

A comparison of classification methods for differentiating fronto‐temporal dementia from Alzheimer's disease using FDG‐PET imaging

Raymond Scott Turner, C. DeCarli, W. Jagust, 2004, Statistics in Medicine.

Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia

Raymond Scott Turner, J. Trojanowski, M. Grossman, 1996, Annals of neurology.

Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration

Sterling C. Johnson, Raymond Scott Turner, Alice D. Brown, 2020, Molecular neurodegeneration.

Polygenic effects on the risk of Alzheimer’s disease in the Japanese population

Raymond Scott Turner, Sherye A. Sirrel, Alice D. Brown, 2024, Alzheimer's research & therapy.

Resting state connectivity predicts implicit sequence learning performance: a replication and extension

Raymond Scott Turner, C. Vaidya, D. Madden, 2014 .